FRAME: A Phase I Trial of Defactinib (FAK Inhibitor) in Combination with Avutometinib (RAF-MEK Clamp) in Patients with Solid Tumours Including Low Grade Serous Ovarian Cancer
crossref(2024)
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined